FDA Inspection 1028356 — Shandong Anxin Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shandong Anxin Pharmaceutical Co., Ltd. on Sep 1, 2017 in Jinan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 1, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinan (China)